This is an excellent discussion so I'm going to include the folks on HIPAALive.
In terms of CE's who use clearinghouses, if the CE is looking to the clearinghouse for translation I think it should be looking for a test of the translation of their non-standard to the standard and a report back on the success of that test. Depending on the extent to which the translation is not successful, there could be quite a bit of work to be done. If the worse case scenario were to occur (translation to the standard is not possible using the current non-standard format), the CE would want to know that ASAP. Though perhaps not a requirement for the April deadline, if the clearinghouse returns successful test results, the CE might want those results tested for compliance yet again by a neutral third party testing system. Marcallee Jackson Long Beach, CA 562-438-6613 -----Original Message----- From: Cynthia Korman [mailto:ckorman@;healthcare-systems.com] Sent: Wednesday, November 06, 2002 7:35 AM To: WEDI SNIP Testing Subworkgroup List Subject: Fw: "Testing" defined for 4/03 deadline? Following is from the HHS HIPAA FAQs web site (today) "Question: Section D of the ASCA compliance extension form specifies a timeframe for testing not later than April 16, 2003. Can you provide a definition of testing, and does it relate to all transactions?" "Answer: ASCA requires that testing begin no later than April 2003. The law itself did not specify what type of testing, (e.g. internal, external,final with trading partners, all transactions, or just one, etc.) HHS interprets this to mean the date requested on the extension form as the date when internal system testing begins for the first transaction the covered entity will test. However, some covered entities will need to begin their external testing sooner than others, especially those that have many trading partners or are implementing many of the transactions. We encourage all covered entities to begin testing as soon as possible." Now, for covered entities, what does "internal testing" mean? A1) Starting work toward certifying transactions, before trading partner testing, perhaps through business associates? But, from the specific covered-entity's perspective, using THAT covered entity's data? A2) Confirming that business associates (software vendors and, for providers and payors, clearinghouses) have started testing? If so, how much detail should the specific CE be getting? A3) On 4/16/03, having hipaa-ready software installed and ready for testing new data capture and generation of hipaa-compliant transactions? A4) For the DDE exception, being scheduled with the trading partners to test hipaa-compliant DDE? What have I missed? - Cynthia --- The WEDI SNIP listserv to which you are subscribed is not moderated. The discussions on this listserv therefore represent the views of the individual participants, and do not necessarily represent the views of the WEDI Board of Directors nor WEDI SNIP. If you wish to receive an official opinion, post your question to the WEDI SNIP Issues Database at http://snip.wedi.org/tracking/. These listservs should not be used for commercial marketing purposes or discussion of specific vendor products and services. They also are not intended to be used as a forum for personal disagreements or unprofessional communication at any time. You are currently subscribed to wedi-testing as: [email protected] To unsubscribe from this list, go to the Subscribe/Unsubscribe form at http://subscribe.wedi.org or send a blank email to [EMAIL PROTECTED] If you need to unsubscribe but your current email address is not the same as the address subscribed to the list, please use the Subscribe/Unsubscribe form at http://subscribe.wedi.org
